Hereditary thrombopathia is an inherited genetic disorder affecting Basset Hound puppies and other breeds, causing abnormal bleeding due to impaired platelet function. This autosomal recessive condition means that a dog must inherit a mutated gene from both parents to show symptoms. Dogs carrying only one copy of the gene are asymptomatic carriers but can pass the disorder on to their offspring. Responsible breeding practices are essential, and affected dogs should never be used for breeding to prevent transmission.
Hereditary thrombopathia has been identified primarily in these breeds:
The disorder affects platelet function, preventing blood from clotting properly. Platelets fail to aggregate and adhere as they should, leading to excessive bleeding, even from minor injuries. This malfunction is due to specific defects in platelet glycoproteins crucial for clotting processes.
The symptoms of thrombopathia resemble other clotting disorders, making diagnosis a challenge. Common clinical signs include:
Blood counts and clotting factor levels in affected dogs are often normal, so standard blood tests may not detect the disorder. Definitive diagnosis requires specialised platelet function tests, usually performed by veterinary specialists. Genetic testing is also available to identify carriers and affected dogs, providing vital information for breeding management.
While there is no cure for hereditary thrombopathia, careful management significantly improves quality of life. Key strategies include:
Effective communication with your vet and regular health checks are essential to manage risks and maintain your dog's wellbeing.
Preventing the spread of thrombopathia is only possible by ensuring that affected dogs are not bred. All dogs intended for breeding should undergo genetic testing to determine their status:
Spaying or neutering dogs diagnosed with thrombopathia is advised to prevent passing the condition to puppies. Breeders should prioritise health screening and genetic counselling to support the health of future generations.
Hereditary thrombopathia is a serious genetic disorder affecting blood clotting in certain dog breeds, particularly Basset Hounds and Finnish Spitz. Early diagnosis through specialised testing and effective management can greatly reduce health risks. Responsible breeding practices including genetic testing and removal of affected dogs from breeding programs are critical to prevent the disorder's spread. If you think your dog may show bleeding-related symptoms, seek veterinary advice promptly to ensure appropriate care and support.
Hereditary thrombopathia is caused by a recessive mutation in the RASGRP1 gene. Because the condition follows an autosomal recessive inheritance pattern, a dog must inherit two copies of the faulty gene — one from each parent — to be affected. Dogs carrying only one copy (carriers) will not show bleeding symptoms but can pass the mutation to their offspring.
DNA tests for the RASGRP1 mutation are commercially available in the UK from laboratories including Laboklin and Animal Genetics, typically priced around £40–£48. Results classify dogs as Clear (no copies of the mutation), Carrier (one copy), or Affected (two copies). Responsible breeders of Basset Hounds and other at-risk breeds should test all breeding stock. A Clear × Carrier pairing will not produce affected puppies, although 50% of offspring may still be carriers. A Clear × Clear pairing guarantees no affected offspring. If you are buying a puppy of an at-risk breed, ask for the parents' DNA test certificates before committing to a purchase.
If a dog with hereditary thrombopathia requires surgery, dental extraction, or is involved in an accident, it is critical that your vet is informed of the diagnosis in advance. Routine pre-anaesthetic blood panels may not include platelet function testing, meaning the defect could be missed during standard pre-surgical screening. Alert your vet explicitly so that platelet function can be assessed and appropriate precautions taken.
In emergency bleeding situations, treatment focuses on supportive care: rest to minimise further blood loss, avoiding aspirin and NSAIDs which further impair platelet function, and — in severe cases — whole blood or platelet-rich plasma transfusions administered by a veterinary specialist. Affected dogs wearing an alert tag or carrying a brief medical card in their records can help ensure any emergency vet has the information needed to act quickly and avoid contraindicated medications. Dogs with thrombopathia can lead full lives with informed veterinary support and careful management of injury risk.
How is hereditary thrombopathia different from thrombocytopenia?
Thrombopathia refers to platelet dysfunction — the platelets are present in normal numbers but do not work correctly. Thrombocytopenia refers to a low platelet count. Both can cause abnormal bleeding, but their causes, diagnosis, and treatment differ significantly.
Can dogs with thrombopathia have surgery?
Yes, but it requires careful planning. Your vet should be informed well in advance so that blood typing, cross-matching, and potential transfusion support can be arranged. Elective procedures should be scheduled when the dog is in good health and blood products are available if needed.
Is there a cure for hereditary thrombopathia?
There is no cure. Management focuses on minimising bleeding risk through activity management, avoiding medications that impair clotting, and addressing any bleeding episodes promptly. The condition is permanent but compatible with a good quality of life under appropriate care.